Abstract: An cable assembly (100) includes an insulated housing (1) extending along a front-to-back direction; a plurality of contacts (2) arranged in a row and supported by the insulated housing, said contacts including three grounding contact members spaced by two pair of signal contact members; a cable (4) including two juxtaposed differential wire pairs (41) respectively enclosed by conductive shielding portions (43); a grounding member (3) including a main portion (31), three finger portions (33) extending forwardly from a front side of the main portion and two arm portions (32) formed at lateral sides of a rear segment of the main portion, said grounding member (3) securely engaged with the cable via the two arm portions thereof griping the conductive shielding portions; and the finger portions soldered to the grounding contact members, and inner conductors of the differential pairs soldered to the signal contact members, respectively.

Abstract: This application discloses a novel process for the synthesis of himbacine analogs, as well as the compounds produced thereby. The synthesis proceeds by alternative routes including the cyclic ketal amide route, the chiral carbamate amide route, and the chiral carbamate ester route. The compounds produced thereby are useful as thrombin receptor antagonists.

Abstract: Devices to be arranged in a master-slave configuration are individually tested using a testing system that ensures that the devices will satisfy an interconnection requirement of that configuration. The testing system configures a first device into one of a master mode of operation and a slave mode of operation, and adjusts frame starting positions of respective traffic flows associated with the configured mode until measured delay parameters of that mode substantially match corresponding ones of a selected set of prospective delay parameters. If the traffic flows of the one configured mode as adjusted are substantially error free, the first device is configured into the other mode, and frame starting positions of respective traffic flows associated with the other configured mode of the first device are adjusted until measured delay parameters of that mode substantially match corresponding ones of the selected set of prospective delay parameters.

Abstract: This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with diketo piperazine and piperadine derivatives that possess unique antiviral activity useful for the treatment of HIV and AIDS.

Abstract: This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with diketo piperazine and piperadine derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.

Abstract: A power supply system for an electronic device includes a first and a second connector, a switch, and a controller. The first connector is used for connecting to a first power source. The second connector is used for connecting to a second power source, wherein the second power source is rechargeable. The switch establishes a connection between the first connector and the second connector so as to allow the first power source to charge the second power source. The controller detects a presence of the first power source and the second power source, and controls the switch to periodically establish the connection at the absence of the second power source, and to continuously establish the connection at the presence of the second power source.

Abstract: A recoverable, safe and reliable valve stent for unidirectional flow of human lumen which can be implanted temporarily or for a long term and is used in the interventional therapy so as to obstruct from anisotropic flow, in the case of lung diseases. It comprises a cylindrical stent made up of memory alloy material. In particular, an elastic diaphragm is arranged inside the cylindrical stent and at least one gap is arranged on the diaphragm so that the spring piece is divided into a bendable section. One end of the cylindrical stent is provided with a fixed rear clip which is used to fix the alloy material making up the cylindrical stent. The rear clip is provided with screwthreads which can be connected with the conveyor. The stent in the present invention is in a structure without hook body, so the stent can be accurately positioned, adjusted and placed or recovered in double directions with strong anti-backflow ability.

Abstract: A testing device for testing a motherboard is provided to include a server, a client terminal computer, a debug card and a receiving device. The server is connected to the client terminal computer, for inquiring test results. The debug card is attached to the motherboard, for getting test data. The receiving device connecting with the debug card transmits the test data to the server via a network. A testing method for testing a motherboard is provided to include the following steps: a debug card getting the test data from the motherboard; sending the test data to a receiving device, the receiving device transmitting the test data to a server, the server collating and analyzing the test data; and a client terminal computer inquiring test results via the server.

Abstract: A device is used for measuring an output voltage of a battery. The device includes a detecting circuit, an encoding circuit, a control circuit, and a processing circuit. The detecting circuit is configured for detecting the output voltage of the battery and generating a first signal, a second signal, and a third signal accordingly. The encoding circuit is configured for generating a first code and a second code according to the first signal and the second signal. The control unit is configured for modifying the second code when the third signal indicates that the output voltage is lower than a predetermined value. The processing unit is configured for generating and outputting display control signals according to the first and second codes. The display control signals are used to control a display panel to display information of the output voltage of the battery.

Abstract: A method and apparatus for user information processing in a network environment. The method performs an orthogonal transform on first and second vectors representing information related to first and second users respectively to obtain first and second transformed vectors. Then, the method splits the first and second transformed vectors into two parts respectively, such that first and second vectors cannot be derived from the first or second parts. The first and second user devices exchange the first part of the first transformed vector and the second part of the second transformed vector. The first and second user devices calculate the inner product of the first parts and the second parts respectively. Finally, the two inner products of the parts are summed to get an inner product of the first and second vectors. Also provided are a method and system for resource recommendation in a network environment.

Abstract: Methods and apparatus are provided for framing synchronization control for a framer/mapper/multiplexor (FMM) device with 1+1 and equipment protection. FMM device are disclosed that synchronize one or more internal signals by changing a phase of the one or more internal signals without changing a frequency of the one or more internal signals based on a desired phase at a destination of each of the one or more internal signals. A programmable synchronization signal may optionally be employed for the synchronization.

Abstract: This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R1 does not exist; W is C or N with the proviso that when W is N, R2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C1-C6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.

Abstract: This invention relates to novel compounds having the formula (I): and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Abstract: A method for reducing dislocation density between an AlGaN layer and a sapphire substrate involving the step of forming a self-organizing porous AlN layer of non-coalescing column-like islands with flat tops on the substrate.

Abstract: The present invention relates to compounds of Formula (I) and to their pharmaceutical compositions, and to their methods of use. These novel compounds provide a treatment for myeloproliferative disorders and cancer.

Abstract: This application discloses a novel process for the synthesis of himbacine analogs, as well as the compounds produced thereby. The synthesis proceeds by alternative routes including the cyclic ketal amide route, the chiral carbamate amide route, and the chiral carbamate ester route. The compounds produced thereby are useful as thrombin receptor antagonists.

Abstract: Methods and compositions for cloning a donor DNA molecule into an acceptor vector at a predetermined location are described. The methods are based on homologous recombination mediated by in vitro treatment of the donor DNA and the acceptor vector with an enzyme cocktail containing an exonuclease and a single-stranded DNA binding protein.

Abstract: This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R1 does not exist; W is C or N with the proviso that when W is N, R2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C1-C6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.

Abstract: This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with alkene piperidine derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.

Abstract: A batch job processing architecture that dynamically creates runtime tasks for batch job execution and to optimize parallelism. The task creation can be based on the amount of processing power available locally or across batch servers. The work can be allocated across multiple threads in multiple batch server instances as there are available. A master task splits the items to be processed into smaller parts and creates a runtime task for each. The batch server picks up and executes as many runtime tasks as the server is configured to handle. The runtime tasks can be run in parallel to maximize hardware utilization. Scalability is provided by splitting runtime task execution across available batch server instances, and also across machines. During runtime task creation, all dependency and batch group information is propagated from the master task to all runtime tasks. Dependencies and batch group configuration are honored by the batch engine.